| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 4e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 3e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |